Montfort Capital Announces Delay in Filing Annual Financial Statements and MD&A, Issuance of Cease Trade Order
Montfort Capital Reports Preliminary Fourth Quarter and Year Ended December 31, 2025 Financial Results
Government approvals secured for the use of Galidesivir as a treatment for Bundibugyo Ebola epidemic in Africa
Alvopetro Announces June Sales Volumes, an Operational Update and Quarterly Natural Gas Pricing Update
